Inhibikase Therapeutics, Inc.
IKT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$11,930 | -$9,916 | -$13,679 | -$12,133 |
| Dep. & Amort. | $24 | $24 | $13 | $7 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $4,209 | $2,042 | $7,908 |
| Change in WC | -$2,148 | $467 | $1,328 | -$1,128 |
| Other Non-Cash | $3,462 | -$358 | $6,192 | $0 |
| Operating Cash Flow | -$10,593 | -$5,574 | -$4,104 | -$5,346 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$452 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$38,996 | $0 | $0 | -$50,111 |
| Inv. Sales/Matur. | $10,250 | $9,844 | $21,506 | $11,349 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$28,746 | $9,844 | $21,054 | -$38,762 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $251 | $0 | $0 | $99,684 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$385 | $32 | $0 | $0 |
| Financing Cash Flow | -$134 | $32 | $0 | $99,684 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$39,473 | $4,301 | $16,951 | $55,577 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $77,743 | $73,441 | $56,491 | $913 |
| End Cash | $38,270 | $77,743 | $73,441 | $56,491 |
| Free Cash Flow | -$10,593 | -$5,574 | -$4,104 | -$5,346 |